MY ACCOUNT | NEWSLETTER |

Study reveals veterinarians are not being proactive with OA

Just 11% of veterinarians discuss joint problems in healthy dogs, according to pet owners


Dog owners are not getting the proactive arthritis information they need from their veterinarian. This key takeaway is based on data collected through the Adequan Canine Osteoarthritis Awareness Study conducted by American Regent Animal Health, makers of Adequan Canine. 

In the study, 575 dog owners were surveyed to assess how much they knew about canine osteoarthritis (OA) and what their veterinarians had discussed with them. The results, released on Jan. 16 during the 2023 VMX conference in Orlando, revealed that many veterinarians are not talking to clients about OA risks in dogs. 

More than half, or 51 percent, of dog owners who participated in the study said their veterinarian had never talked to them about arthritis or other joint problems in their dog. Of those who had discussed joint issues with their veterinarian, 59 percent said they brought up the subject themselves. 

Additional findings from the study include:

  • 43 percent of dog owners said they knew “nothing” or “just a little bit” about canine osteoarthritis and joint problems.
  • Just 11 percent of dog owners said their veterinarian had educated them about joint problems proactively, when their dog seemed healthy.
  • More than one in five, or 21 percent, of those surveyed reported owning a breed known to be at high risk for OA. This includes Labrador retrievers, German shepherds, golden retrievers, bulldogs or rottweilers.
  • 59 percent of dog owners said they were unfamiliar with disease-modifying osteoarthritis drugs (DMOAD), an FDA-regulated drug category. And 13 percent said the same about nonsteroidal anti-inflammatory drugs (NSAIDs).

With one in five dogs over the age of one suspected to have OA, the disease is the most common cause of chronic pain in dogs and is typically diagnosed between the ages of eight and 13. Although advanced age can contribute to the progression of Oat, it is important to recognize the link between orthopedic disease and the development of OA in younger dogs. Treating OA early in a dog’s life is necessary to help delay further joint damage. 

During the session at VMX, experts discussed solutions that veterinary teams can implement to be more proactive about OA. The experts said to:

  • Make OA a priority topic, discuss it with owners at every visit.
  • Look for the signs. Educate dog owners about the early signs of OA, regardless of the dog’s age.
  • Create a protocol. Establish a consistent protocol for diagnosing and treating OA and make the protocol part of clinic culture.
  • Treat with a DMOAD. Recommend a disease-modifying osteoarthritis drug for dogs to help slow the progression of OA. 

Learn more about canine OA and treatment options at: adequancanine.com

Like3
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top